- Home
- FBRT vs MDXG Comparison
FBRT vs MDXG Comparison
Compare FBRT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRT
- MDXG
- Stock Information
- Founded
- FBRT 2012
- MDXG 2006
- Country
- FBRT United States
- MDXG United States
- Employees
- FBRT N/A
- MDXG N/A
- Industry
- FBRT Real Estate Investment Trusts
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- FBRT Real Estate
- MDXG Health Care
- Exchange
- FBRT Nasdaq
- MDXG Nasdaq
- Market Cap
- FBRT 918.2M
- MDXG 1.1B
- IPO Year
- FBRT 1985
- MDXG N/A
- Fundamental
- Price
- FBRT $11.04
- MDXG $7.03
- Analyst Decision
- FBRT Strong Buy
- MDXG Buy
- Analyst Count
- FBRT 5
- MDXG 1
- Target Price
- FBRT $14.90
- MDXG $12.00
- AVG Volume (30 Days)
- FBRT 633.8K
- MDXG 794.2K
- Earning Date
- FBRT 07-30-2025
- MDXG 07-30-2025
- Dividend Yield
- FBRT 12.87%
- MDXG N/A
- EPS Growth
- FBRT 18.52
- MDXG N/A
- EPS
- FBRT 0.98
- MDXG 0.21
- Revenue
- FBRT $207,768,000.00
- MDXG $363,774,000.00
- Revenue This Year
- FBRT $28.21
- MDXG $9.55
- Revenue Next Year
- FBRT $2.40
- MDXG $11.43
- P/E Ratio
- FBRT $11.26
- MDXG $34.15
- Revenue Growth
- FBRT 16.05
- MDXG 6.85
- 52 Week Low
- FBRT $9.79
- MDXG $5.47
- 52 Week High
- FBRT $13.74
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- FBRT 55.86
- MDXG 51.94
- Support Level
- FBRT $10.94
- MDXG $7.06
- Resistance Level
- FBRT $11.25
- MDXG $7.27
- Average True Range (ATR)
- FBRT 0.17
- MDXG 0.22
- MACD
- FBRT 0.05
- MDXG -0.02
- Stochastic Oscillator
- FBRT 75.86
- MDXG 25.00
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.